Manuel Litchman M.D. is CEO & President at MUSTANG BIO, INC. (MBIO). They have made 9 open-market trades across 1 company since 2018, most recently 2026-04-24.
CIK 0001709485
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
8 open-market purchases totalling $3.6M since 2018, against 1 sale. Across 8 scored buys the stock is up 1.9% at ninety days, and 4.5 points behind the S&P over the same stretch.
8 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| MBIO | 1,615 | $614 |
Shares reported on the most recent Form 4, priced at the 2026-04-27 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 38% | 25% | 50% |
| Avg Move | -2.3% | -0.6% | +1.9% |
| Alpha | -2.1% | -2.7% | -4.5% |
| Scored | 8 | 8 | 8 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MBIO | BUY | 2022-03-18 | 2023-04-03 | $0.63 | $6K | -29.1% | -15.1% | +26.8% |
| MBIO | BUY | 2021-10-27 | 2021-11-08 | $2.24 | $146K | -11.6% | -15.1% | -57.0% |
| MBIO | BUY | 2021-07-30 | 2021-08-05 | $2.91 | $502K | -4.0% | -1.3% | -17.1% |
| MBIO | BUY | 2021-03-05 | 2021-03-15 | $3.12 | $1.0M | -8.5% | -15.9% | -2.6% |
| MBIO | BUY | 2020-12-15 | 2020-12-22 | $2.91 | $291K | +17.6% | +34.1% | -1.1% |
| MBIO | BUY | 2020-06-11 | 2020-06-15 | $3.25 | $1000K | -11.0% | -11.0% | +4.8% |
| MBIO | SELL | 2020-05-22 | 2021-04-29 | $3.04 | $38K | -9.0% | +3.1% | -11.5% |
| MBIO | BUY | 2020-05-14 | 2020-05-22 | $2.96 | $533K | +17.3% | -3.3% | +6.8% |
| MBIO | BUY | 2018-11-20 | 2018-12-18 | $3.71 | $104K | +10.5% | +22.9% | +54.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.